Muscarinic receptor subtypes in airways
References (48)
- et al.
Eur. J. Pharmacol.
(1982) - et al.
Chest
(1989) - et al.
Eur. J. Pharmacol.
(1989) - et al.
Eur J Pharmacol
(1987) - et al.
Neuropharmacology
(1984) - et al.
Eur. J. Pharmacol.
(1988) - et al.
Pulm. Pharmacol.
(1990) - et al.
Eur. J. Pharmacol.
(1989) - et al.
Eur. J. Pharmacol.
(1988) Am. Rev. Respir. Dis.
(1986)
Am J Physiol
(1990)
Am. Rev. Respir. Dis.
(1990)
Neursci Lett
(1989)
J. Appl. Physiol.
(1990)
Am Rev Respir Dis
(1990)
Trends Pharmacol. Sci.
(1989)
Am J Resp Cell Mol Biol
(1992)
J. Pharmacol. Exp. Ther.
(1987)
J. Appl. Physiol.
(1988)
Physiol Rev
(1992)
Am. Rev. Respir. Dis.
(1989)
Int J Clin Pharmacol Ther Toxicol
(1986)
Int J Clin Pharmacol Ther Toxicol
(1987)
Eur Resp J
(1992)
Cited by (223)
Treatment with long acting muscarinic antagonists stimulates serum levels of irisin in patients with COPD
2018, Pulmonary Pharmacology and TherapeuticsGenetics in Asthma and COPD
2015, Murray and Nadel's Textbook of Respiratory Medicine: Volume 1,2, Sixth EditionDevelopment of the Innervation of the Lower Airways: Structure and Function. Structure and Function.
2014, The Lung: Development, Aging and the Environment: Second EditionTriple Therapy in COPD: Can We Welcome the Reduction in Cardiovascular Risk and Mortality?
2022, Frontiers in Medicine
Copyright © 1993 Published by Elsevier Inc.